Castle Biosciences (NasdaqGM:CSTL) Update / briefing March 23, 2026 04:30 PM ET Company ParticipantsCamilla Zuckero - VP of Investor Relations and Corporate AffairsCatherine Schulte - Director of Life Sciences Equity ResearchDerek Maetzold - President and CEOMason Carrico - Managing Director of Medical Technology Equity ResearchMatthew Goldberg - SVP of MedicalMichael Guenther - Surgical OncologistConference Call ParticipantsCarlos Penikis - Senior Equity Research AnalystThomas Flaten - Senior Equity Resear ...